Compound Profiles
Hexarelin
Examorelin | Synthetic Growth Hormone Secretagogue
Hexarelin binds to the growth hormone secretagogue receptor 1a (GHS-R1a) in the brain and pituitary gland. This binding initiates a signaling cascade that stimulates somatotroph cells in the anterior pituitary to produce and release growth hormone.
MK-677
Ghrelin Receptor Agonist | Oral Growth Hormone Secretagogue
Selectively binds GHS-R1a receptors in hypothalamus and pituitary, triggering pulsatile growth hormone release while maintaining natural circadian patterns..
Combined Organ Load
Shared Safety Flags
Frequently Asked Questions
Can I take Hexarelin with MK-677?
Yes, but with caution. Both Hexarelin and MK-677 stimulate the ghrelin receptor. Additive GH release may increase side effects (water retention, joint pain, blood glucose elevation). Consider using one at a time or reducing doses. Regular monitoring is advised.
Is Hexarelin and MK-677 safe together?
Based on pharmacological analysis, this combination is considered monitor. However, shared safety flags include: carcinogenic risk, insulin disrupting, teratogenic. Monitor accordingly.
What are the interactions between Hexarelin and MK-677?
Both Hexarelin and MK-677 stimulate the ghrelin receptor. Additive GH release may increase side effects (water retention, joint pain, blood glucose elevation). Consider using one at a time or reducing doses. This assessment has 51% confidence and is inferred from pharmacological mechanism analysis.
How should I time Hexarelin and MK-677?
Hexarelin has a half-life of 1-2 hours and MK-677 has a half-life of ~24 hours. No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.
This interaction analysis is compiled from research literature and pharmacological mechanism data. This assessment is inferred from known mechanisms and may not reflect all real-world outcomes. Always consult a healthcare professional before combining compounds.